Literature DB >> 843146

Renin reactivity as a determinant of responsiveness to antihypertensive treatment.

M A Weber, J A Lopez-Ovejero, J I Drayer, D B Case, J H Laragh.   

Abstract

In 79 patients with essential hypertension, treatment with propranolol hydrochloride and chlorthalidone together produced significantly greater falls in both systolic and diastolic blood pressures than were obtained with either drug alone. There were no differences between patients in the high, normal, and low renin subgroups in their responsiveness to this combination. Although plasma renin level during combined treatment was twice as high as it was in the untreated control, aldosterone excretion actually decreased. These divergent changes may have been influenced by the renin-raising and aldosterone-lowering effects of the marked hypokalemia observed during combined treatment. By comparison with patients whose blood pressures fell, treatment in nonresponding patients produced even greater body weight reductions and significantly higher renin and aldosterone values. It is possible that increased activity of the renin axis, triggered by excessive volume depletion and perhaps by changes in potassium balance, were responsible for sustaining the high levels of blood pressure in those patients failing to respond to treatment.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 843146

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  5 in total

1.  Influence of metoprolol, alone and in combination with a thiazide diuretic, on blood pressure, plasma volume, extracellular volume and glomerular filtration rate in essential hypertension.

Authors:  S Rasmussen; K Rasmussen
Journal:  Eur J Clin Pharmacol       Date:  1979-06-12       Impact factor: 2.953

2.  Recent pathogenic aspects in essential hypertension and hypertension associated with diabetes mellitus.

Authors:  P Weidmann
Journal:  Klin Wochenschr       Date:  1980-10-01

3.  The case for low dose diuretics in hypertension: comparison of low and conventional doses of cyclopenthiazide.

Authors:  G McVeigh; D Galloway; D Johnston
Journal:  BMJ       Date:  1988-07-09

4.  Labetalol in severe and resistant hypertension.

Authors:  L C Williams; M J Murphy; V Parsons
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

Review 5.  Comparative cardiovascular effects of drugs used for hypertension.

Authors:  M Burnier; B Waeber; J Nussberger; H R Brunner
Journal:  Drugs       Date:  1990       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.